Bioequivalence Study of Fenofibrate 160mg Tablets Under Fed Conditions
NCT00775359
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Fenofibrate 160 mg tablets
Sponsor
Ranbaxy Laboratories Limited